SCHEMBL4322679

SCHEMBL4322679

O=C(Nc1ccc(C(=O)Nc2ccccc2C=Cc2n[nH]c3ccccc23)s1)c1cccs1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
MAPT P10636 3/20 0.42
KDR P35968 2/20 0.41
TSHR P16473 2/20 0.40
POLB P06746 2/20 0.40
STK33 Q9BYT3 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PARP1 P09874 1/20 0.40
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
EPHB3 P54753 1/20 0.40
MAPK1 P28482 1/20 0.39
KDM4E B2RXH2 2/20 0.39
HSD17B10 Q99714 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HPGD P15428 1/20 0.39
APLNR P35414 1/20 0.39
CASP3 P42574 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4322671 1.00 ALDH1A1 (0.42) ALDH1A1MAPTKDRTSHRPOLB
SCHEMBL4314375 0.93 MAPT (0.47) ALDH1A1MAPTKDRTSHRPOLB
SCHEMBL4314371 0.93 MAPT (0.47) ALDH1A1MAPTKDRTSHRPOLB
SCHEMBL4313556 0.89 KDR (0.42) MAPTKDRSTK33EPHB3KDM4E
SCHEMBL4313552 0.89 KDR (0.42) MAPTKDRSTK33EPHB3KDM4E
SCHEMBL4314947 0.86 KDR (0.41) ALDH1A1KDRSTK33NPC1EPHB3
SCHEMBL4314953 0.86 KDR (0.41) ALDH1A1KDRSTK33NPC1EPHB3
SCHEMBL4314846 0.85 ALDH1A1 (0.46) ALDH1A1MAPTKDRPOLBSTK33
SCHEMBL4314836 0.85 ALDH1A1 (0.46) ALDH1A1MAPTKDRPOLBSTK33
SCHEMBL4313824 0.83 SMN1; SMN2 (0.46) ALDH1A1MAPTKDRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 ALDH1A1 1250/4885MAPT 4175/4885KDR 75/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.